Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
This article simplifies altcoins that beginners find approachable, outlining key features, how they differ from BTC, and practical steps to research safely.
20,932 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
San Francisco rolls out the Year of the Fire Horse parade with Olympic champion Eileen Gu as grand marshal, spotlight...
AMD’s surprise move to buy MEXT promises AI-driven memory optimization that could trim data center costs. Learn what ...
CrowdStrike’s ARR growth has reaccelerated, but does that make the stock a buy? This guide breaks down ARR health, ma...
As India intensifies crypto oversight, the local premium for USDT widens to 8.5%, forcing rupee buyers into costlier ...
A $3 million nest egg can fund comfortable retirement, but market swings and drawdown fears keep many retirees with m...
Bill Maher accepts the Mark Twain Prize at the Kennedy Center, a night that blends comedy with urgent questions about...
Micron Technology races higher on AI memory demand and supply tightness. This piece outlines why investors may consid...
Investors are buzzing about a potential shift in how Rocket Lab does business. This article delves into what a SpaceX...
A high-profile insider sale at Urban Outfitters has investors weighing risk and opportunity. Learn how to interpret t...
Inflation is back, and 2026 could test investors in new ways. This guide breaks down what inflation surging: here's t...
A widely watched energy- income ETF offers monthly-like payouts but comes with uneven distributions and a yield below...